Prism Medico and Pharmacy Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 1, 2022
Operating Revenue	24.43	6.32	29.25	12.71	84.44
Other Revenue	-	-	0	-	0
Revenue	24.43	6.32	29.25	12.71	84.44
Revenue Growth (YoY)	286.68%	-78.40%	130.21%	-84.95%	-49.63%
Cost of Revenue	15.69	4.49	25.61	11.41	86.28
Gross Profit	8.75	1.83	3.65	1.3	-1.84
Selling, General & Admin	4.64	2.6	5.02	2.27	3.06
Other Operating Expenses	-0.24	-0.08	-0.61	-0.02	-
Operating Expenses	4.43	2.56	4.46	2.32	3.15
Operating Income	4.31	-0.73	-0.82	-1.02	-4.99
Interest Expense	-	-	-	-0	-0.01
Interest & Investment Income	-	-	0	-	-
Currency Exchange Gain (Loss)	-0	0.09	0.6	-	-
Other Non Operating Income (Expenses)	-0.01	-0.02	-0.07	-0	0
EBT Excluding Unusual Items	4.3	-0.66	-0.29	-1.02	-4.99
Pretax Income	4.3	-0.66	-0.28	-1.02	-4.99
Income Tax Expense	1.11	-0.17	-0.07	-0.26	-1.29
Net Income	3.18	-0.49	-0.21	-0.76	-3.7
Net Income to Common	3.18	-0.49	-0.21	-0.76	-3.7
Shares Outstanding (Basic)	601	6	6	6	6
Shares Outstanding (Diluted)	601	6	6	6	6
Shares Change (YoY)	9807.84%	-	3.31%	-3.21%	0.01%
EPS (Basic)	0.01	-0.08	-0.04	-0.13	-0.61
EPS (Diluted)	0.01	-0.08	-0.04	-0.13	-0.61
Gross Margin	35.79%	29.02%	12.46%	10.23%	-2.18%
Operating Margin	17.65%	-11.54%	-2.80%	-8.01%	-5.90%
Profit Margin	13.03%	-7.71%	-0.73%	-6.00%	-4.38%
EBITDA	4.35	-0.69	-0.77	-0.95	-4.9
EBITDA Margin	17.79%	-10.87%	-2.61%	-7.49%	-5.80%
D&A For EBITDA	0.04	0.04	0.05	0.07	0.09
EBIT	4.31	-0.73	-0.82	-1.02	-4.99
EBIT Margin	17.65%	-11.54%	-2.80%	-8.01%	-5.90%
Effective Tax Rate	25.89%	-	-	-	-
Revenue as Reported	24.7	6.48	30.48	12.72	84.44
Advertising Expenses	0.27	0.17	0.34	-	-